70 related articles for article (PubMed ID: 34494528)
1. [Prognosis and Related Factors of Patients with Pathological Complete Response after Neoadjuvant Therapy for Gastric Cancer].
Wang TB; Zhou H; Zhang XJ; Sun CY; Guo CG; Chen YT; Zhou AP; Jin J; Zhao DB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Aug; 43(4):571-578. PubMed ID: 34494528
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy.
Guo F; Xiang X; Huang Y; Chen A; Ma L; Zhu X; Abdulla Z; Jiang W; Li J; Li G
Int J Clin Oncol; 2023 Sep; 28(9):1158-1165. PubMed ID: 37318644
[TBL] [Abstract][Full Text] [Related]
3. Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: a real-world study.
Sun C; Niu P; Zhang X; Zhao L; Wang W; Luan X; Han X; Chen Y; Zhao D
BMC Cancer; 2023 Oct; 23(1):996. PubMed ID: 37853387
[TBL] [Abstract][Full Text] [Related]
4. Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancer.
Yang J; Li J; Deng Q; Chen Z; He K; Chen Y; Fu Z
BMC Cancer; 2023 Mar; 23(1):246. PubMed ID: 36918834
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Chemo-Radiation Using IGRT in Patients with Locally Advanced Gastric Cancer.
Shen J; Lian X; Guan Q; He L; Zhang F; Shen J
Curr Oncol; 2022 Oct; 29(10):7450-7460. PubMed ID: 36290863
[TBL] [Abstract][Full Text] [Related]
6. Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment.
Liu Z; Wang Y; Shan F; Ying X; Zhang Y; Li S; Jia Y; Miao R; Xue K; Li Z; Li Z; Ji J
BMC Gastroenterol; 2021 Jul; 21(1):283. PubMed ID: 34246249
[TBL] [Abstract][Full Text] [Related]
7. Effect of neoadjuvant treatment combined with radical gastrectomy on postoperative complications and prognosis of gastric cancer patients.
Zhou Y; Tian Z; Zeng J; Zhou W; Wu K; Shen W
Scand J Gastroenterol; 2021 Nov; 56(11):1343-1348. PubMed ID: 34415219
[TBL] [Abstract][Full Text] [Related]
8. [Study on the dynamic changes of peripheral platelet-to-lymphocyte ratio in the prognosis of neoadjuvant chemotherapy patients with gastric cancer].
Hua KL; Huo MK; Dong ZC; Li S; Wang PJ; Li Y; Ren YK
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(12):858-863. PubMed ID: 35330579
[No Abstract] [Full Text] [Related]
9. Development and validation of a nomogram to predict pathological complete response in patients with locally advanced gastric adenocarcinoma treated with neoadjuvant chemotherapy in combination with PD-1 antibodies.
Li L; Chen G; Chen EY; Strickland MR; Zhao W; Zhang J; Li Z
J Gastrointest Oncol; 2023 Dec; 14(6):2373-2383. PubMed ID: 38196541
[TBL] [Abstract][Full Text] [Related]
10. Does postoperative chemotherapy improve overall survival of patients with ypT1-2N0 cancer?
Su P; Zhang Y; Yu T; Jiang L; Kang W; Liu Y; Yu J
World J Surg Oncol; 2022 Dec; 20(1):408. PubMed ID: 36572874
[TBL] [Abstract][Full Text] [Related]
11. Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international study.
Lin JX; Tang YH; Zhou WX; Desiderio J; Parisi A; Xie JW; Wang JB; Cianchi F; Antonuzzo L; Borghi F; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Staderini F; Marano A; Peluso C; Li P; Zheng CH; Ma YB; Huang CM
Clin Nutr; 2021 Aug; 40(8):4980-4987. PubMed ID: 34364237
[TBL] [Abstract][Full Text] [Related]
12. High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study.
Shen JG; Shen J; Teng RY; Wang LB; Zhao WH; Wang QC
Pathol Oncol Res; 2021; 27():603838. PubMed ID: 34257562
[TBL] [Abstract][Full Text] [Related]
13. Pathologic Complete Response Following Neoadjuvant Therapy for Gastric Adenocarcinoma: A National Cancer Database Analysis on Incidence, Predictors, and Outcomes.
Kaltenmeier C; Althans A; Mascara M; Nassour I; Khan S; Hoehn R; Zureikat A; Tohme S
Am Surg; 2021 Jul; 87(7):1145-1154. PubMed ID: 33342268
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival results of patients with locally advanced gastric cancer and pathological complete response after neoadjuvant chemotherapy and resection.
Wang T; Wang N; Zhou H; Zhou A; Jin J; Chen Y; Zhao D
Transl Cancer Res; 2020 Feb; 9(2):529-535. PubMed ID: 35117397
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer.
Jiang L; Ma Z; Ye X; Kang W; Yu J
World J Surg Oncol; 2021 Feb; 19(1):44. PubMed ID: 33563277
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer.
Tang X; Li M; Wu X; Guo T; Zhang L; Tang L; Jia F; Hu Y; Zhang Y; Xing X; Shan F; Gao X; Li Z
Oncoimmunology; 2022; 11(1):2135819. PubMed ID: 36268179
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors and Prognostic Impact of Postoperative Complications in Patients with Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy.
Yu H; Xu L; Yin S; Jiang J; Hong C; He Y; Zhang C
Curr Oncol; 2022 Sep; 29(9):6496-6507. PubMed ID: 36135080
[TBL] [Abstract][Full Text] [Related]
18. Predicting survival in locally advanced gastric cancer using prognostic factors - neoadjuvant rectal score and downstaging depth score.
Tamam S; Culcu S; Erözkan K; Benk MŞ; Azılı C; Altınsoy E; Ersöz Ş; Unal AE
S Afr J Surg; 2024 Mar; 62(1):72-79. PubMed ID: 38568130
[TBL] [Abstract][Full Text] [Related]
19. Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer.
Lin GT; Huang JB; Lin JL; Lin JX; Xie JW; Wang JB; Lu J; Zheng CH; Huang CM; Li P
Front Immunol; 2022; 13():1061044. PubMed ID: 36569876
[TBL] [Abstract][Full Text] [Related]
20. Impact of the Interval between Neoadjuvant Chemotherapy and Gastrectomy on Pathological Response and Survival Outcomes for Patients with Locally Advanced Gastric Cancer: A Meta-analysis.
Naveed S; Banday SZ; Qari H; Zahoor S; Batoo AJ; Wahid MA; Haq MFU
Euroasian J Hepatogastroenterol; 2022; 12(2):81-91. PubMed ID: 36959991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
